Alcresta Infused With $10M Series B To Get First Product To Market
This article was originally published in The Pink Sheet Daily
Executive Summary
The Massachusetts nutritionals company has guaranteed it can transition from a development company to a commercial company without the help of a partner due to a recent infusion of cash but hopes to strike partnerships for certain indications and regions once the product gets to market.